Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-025642
Filing Date
2025-03-19
Accepted
2025-03-19 17:10:27
Documents
5
Effectiveness Date
2025-03-19

Document Format Files

Seq Description Document Type Size
1 S-8 tm259725d2_s8.htm S-8 61173
2 EXHIBIT 5.1 tm259725d2_ex5-1.htm EX-5.1 9165
3 EXHIBIT 23.1 tm259725d2_ex23-1.htm EX-23.1 2408
4 EX-FILING FEES tm259725d2_ex-filingfees.htm EX-FILING FEES 34087
5 GRAPHIC tm259725d2_ex5-1img001.jpg GRAPHIC 9434
  Complete submission text file 0001104659-25-025642.txt   121045
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285930 | Film No.: 25753636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)